New product
Discontinuation for GLP-1s is not clinically supported at this time, as current literature suggests members need to stay on the medication indefinitely
Many patients find it helpful to note the date, site, and any reactions in a medication diary or smartphone app
Mild renal impairment and the efficacy and safety of liraglutide
We think of this market as a duopoly, says Emily Field, equity analyst at Barclays Investment Bank in London
NEWS Obesity-drug pioneers win prestigious Lasker Award for medical science Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access 196,21 per year only 3,77 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout doi: References Kieffer, T
